(Q84975509)
Statements
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials (English)
Andrea Willer
Joachim Gerss
Thorsten König
Dieter Franke
Hans-Jürgen Kühnel
Günter Henze
Arendt von Stackelberg
Anja Möricke
Martin Schrappe
Joachim Boos
Claudia Lanvers-Kaminsky
22 September 2011